TP53 and cancer: The oncogenic interplay between NRF2 and mutp53 has been nicely demonstrated in vivo where, in a K-ras/p53 double mutant mouse model, Nrf2 depletion decreases pancreatic carcinogenesis and cancer invasion [80].